Purchase Order 75P00219P00126
- Not listed
- This federal contract award is for the delivery of influenza vaccines to the U.S. Department of Veterans Affairs (VA) and other government agencies. The prime contractor is Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and production. The contract has a ceiling value of $348,461.50 and an ultimate completion date of April 14, 2023. Seqirus USA Inc. has been awarded numerous federal contracts and delivery orders to provide influenza vaccines to...
- This federal contract award to Seqirus USA Inc. is for the delivery of flu vaccines. The $1,241,993.00 fixed-price purchase order was awarded on June 30, 2020 by the U.S. Department of Health and Human Services and has a completion date of July 30, 2020. Seqirus is a global biotechnology company that specializes in the manufacturing and delivery of influenza vaccines to various federal government agencies. The company has been awarded multiple Indefinite Delivery Contracts (IDCs) with agencies...
- This federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration is for the delivery of flu vaccines to support the VA's immunization program. The $189,677.88 firm fixed price delivery order was issued to the prime contractor, Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. Seqirus USA Inc. has a history of providing influenza vaccines to various federal agencies, including the Department of Defense, Department of...
- This federal contract award is for the delivery of SEQIRUS INFLUENZA VACCINE to the U.S. Department of Veterans Affairs (VA). The contract, valued at $390,757.50, was awarded to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The contract is a firm fixed-price delivery order contract with a completion date of June 30, 2025. Seqirus USA Inc. is a foreign-owned, for-profit biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to...
- The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
- This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Seqirus USA Inc., a global biotechnology company specializing in the development, manufacturing, and delivery of influenza vaccines. The award, valued at $339,868.00, is a firm-fixed-price delivery order contract for the procurement of pharmaceutical products for the VA's Pharmacy Ordering Officer for Fiscal Year 2017. The contract does not have a set-aside designation. Seqirus USA Inc. is the prime contractor...
- The U.S. Department of Health and Human Services has awarded a $22,428.00 firm-fixed-price purchase order contract to Seqirus USA Inc., a global biotechnology company, for the delivery of flu vaccines during the 2024-2025 season. This award is not a set-aside contract. Seqirus, through its Seqirus Usa, Inc. division, is a major supplier of influenza vaccines to various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and Human...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccines, to provide influenza vaccines. The $180,670 contract has a completion date of February 2, 2023. Seqirus, through its Seqirus USA, Inc. Division, has provided influenza vaccines to various federal government customers, including the Department of Defense, Department of Justice Bureau of Prisons, and...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $390,617.50 contract is for the delivery of flu vaccines to the VA in Richmond, Virginia. Seqirus USA Inc.'s Seqirus Usa, Inc. Division has provided influenza vaccines to various federal agencies in the past, including the Department of Defense, Department of Justice Bureau of...
This federal contract award is for the delivery of flu vaccines by Seqirus USA Inc., a global biotechnology company, to various U.S. government agencies including the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and Department of Justice. The contract, valued at $1,351,500.00, is a Firm Fixed Price Purchase Order with a completion date of July 7, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous federal contracts to supply influenza vaccines in different formulations and presentations, supporting immunization efforts for military personnel, veterans, federal inmates, and the general public. The company holds several high-value Indefinite Delivery Contracts (IDCs) and Indefinite Delivery Indefinite Quantity (IDIQ) contracts with agencies such as the Defense Logistics Agency, Centers for Disease Control and Prevention, and the VA National Acquisition Center, demonstrating its capacity to meet large-scale federal vaccine requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 8/1/24 | |
| Not listed | Not listed | $1.4m | 6/7/19 |